Heart Disease Clinical Trials in Atlanta

Showing 181-200 of 252 trials

Pharmacodynamic and Pharmacokinetic Study of BiDil Extended-release Capsules and Commercial BiDil Tablets

NCT02522208

This study will investigate cardiovascular parameters using echocardiographic and pharmacokinetics during a daily dose of BiDil and BiDil Extended Release (XR) compared to a study drug free day.

Heart Failure

Arbor Pharmaceuticals, Inc.12 participantsStarted Sep 2015

Anniston, Alabama, United States • Coral Gables, Florida, United States • Jacksonville, Florida, United States +2 more locations

COMPLETEDPHASE3< 1 mile

Randomized, Double-Blind, Placebo Controlled Study of the Short Term Clinical Effects of Tolvaptan in Patients Hospitalized for Worsening Heart Failure With Challenging Volume Management

NCT01584557

The purpose of this study is to evaluate the short term efficacy and safety of tolvaptan in subjects hospitalized for worsening heart failure who have volume overload and one of the following: renal insufficiency, or hyponatremia or inadequate response to diuretic therapy. The primary variable for assessing efficacy will be self-assessed 7-point dyspnea score at 8 and 16 hours.

Heart Failure

Cardiovascular Clinical Sciences Inc250 participantsStarted Jun 2012

Birmingham, Alabama, United States • Huntsville, Alabama, United States • Los Angeles, California, United States +34 more locations

Pharmacodynamic and Pharmacokinetic Study of BiDil Extended-release Capsules and Commercial BiDil Tablets

Randomized, Double-Blind, Placebo Controlled Study of the Short Term Clinical Effects of Tolvaptan in Patients Hospitalized for Worsening Heart Failure With Challenging Volume Management

Heart Disease Trials in Other Cities

GORE Flow Reversal System and GORE Embolic Filter Extension Study

Investigation of the Athero-Protective Effects of Clopidogrel

A Pharmacodynamic Study With Ticagrelor in African American Patients

Evaluating the Effectiveness of Sildenafil at Improving Health Outcomes and Exercise Ability in People With Diastolic Heart Failure (The RELAX Study)

Single Ascending Doses of GGF2 in Patients With Left Ventricular Dysfunction and Symptomatic Heart Failure

Does Prophylactic Coronary Artery Revascularization for High Risk Patients Reduce Long-term Risk of Mortality

Safety and Efficacy of Mipomersen (ISIS 301012) As Add-on Therapy in High Risk Hypercholesterolemic Patients

A Study of RO4905417 in Patients Undergoing Coronary Artery Bypass Graft (CABG) Surgery

Study To Evaluate D-Ribose For The Treatment of Congestive Heart Failure

Type 2 Diabetes Evaluation of Ranolazine in Subjects With Chronic Stable Angina

Niacin Plus Statin to Prevent Vascular Events

A Phase IIb Study to Investigate the Efficacy and Tolerability of Lower Doses Cinaciguat (25 µg/h, 10 µg/h) Given Intravenously to Patients With Acute Decompensated Chronic Congestive Heart Failure (ADHF)

TAXUS Libertē Post Approval Study

Evaluation of Vepoloxamer in Chronic Heart Failure

Clinical Evaluation of the Physiological Diagnosis Function in the PARADYM CRT Device

Assessment of Catheter-based Interrogation and Standard Techniques for Fractional Flow Reserve Measurement

Radial Artery Access With Ultrasound Trial

A Phase 1/2 Study of High-dose Genetically Targeted Enzyme Replacement Therapy for Advanced Heart Failure

Other Conditions in Atlanta